Analgesic Efficacy of Maxigesic in Breast Cancer Surgery

Summary

The present study aims to find a perioperative analgesic method that provides sufficient analgesia while reducing immune compromise in cancer surgery. This study is to investigate the analgesic effect and safety of Maxigesic inj. (a combination of acetaminophen 1000 mg and ibuprofen 300 mg), which is added to opioid-based IV-PCA in patients undergoing breast cancer surgery.

Timeline

Start

2023-12-28

Primary completion

2025-12-26

Completion

2025-12-26

Drugs

Indications